261 related articles for article (PubMed ID: 26519601)
21. Neuroprotective effects of cerium oxide nanoparticles on experimental stress-induced depression in male rats.
Zavvari F; Nahavandi A; Shahbazi A
J Chem Neuroanat; 2020 Jul; 106():101799. PubMed ID: 32371049
[TBL] [Abstract][Full Text] [Related]
22. Liver-targeted nanoparticles delivering nitric oxide reduce portal hypertension in cirrhotic rats.
Perramón M; Navalón-López M; Fernández-Varo G; Moreno-Lanceta A; García-Pérez R; Faneca J; López-Moya M; Fornaguera C; García-Villoria J; Morales-Ruiz M; Melgar-Lesmes P; Borrós S; Jiménez W
Biomed Pharmacother; 2024 Feb; 171():116143. PubMed ID: 38219387
[TBL] [Abstract][Full Text] [Related]
23. Epigallocatechin-3-gallate (EGCG) reduces liver inflammation, oxidative stress and fibrosis in carbon tetrachloride (CCl4)-induced liver injury in mice.
Tipoe GL; Leung TM; Liong EC; Lau TY; Fung ML; Nanji AA
Toxicology; 2010 Jun; 273(1-3):45-52. PubMed ID: 20438794
[TBL] [Abstract][Full Text] [Related]
24. Transcriptional profile of genes involved in oxidative stress and antioxidant defense in PC12 cells following treatment with cerium oxide nanoparticles.
Ciofani G; Genchi GG; Mazzolai B; Mattoli V
Biochim Biophys Acta; 2014 Jan; 1840(1):495-506. PubMed ID: 24135455
[TBL] [Abstract][Full Text] [Related]
25. Neuro-protective effects of cerium and yttrium oxide nanoparticles on high glucose-induced oxidative stress and apoptosis in undifferentiated PC12 cells.
Ghaznavi H; Najafi R; Mehrzadi S; Hosseini A; Tekyemaroof N; Shakeri-Zadeh A; Rezayat M; Sharifi AM
Neurol Res; 2015 Jul; 37(7):624-32. PubMed ID: 25786672
[TBL] [Abstract][Full Text] [Related]
26. Cerium dioxide nanoparticles possess anti-inflammatory properties in the conditions of the obesity-associated NAFLD in rats.
Kobyliak N; Virchenko O; Falalyeyeva T; Kondro M; Beregova T; Bodnar P; Shcherbakov O; Bubnov R; Caprnda M; Delev D; Sabo J; Kruzliak P; Rodrigo L; Opatrilova R; Spivak M
Biomed Pharmacother; 2017 Jun; 90():608-614. PubMed ID: 28411553
[TBL] [Abstract][Full Text] [Related]
27. [The anti-portal hypertension effect of oleanolic acid in CCl4-induced cirrhosis rats].
Liu CH; Huang XT; Li YY; Zheng X; Li N; Mi SQ; Wang NS
Zhong Yao Cai; 2012 Jun; 35(6):930-5. PubMed ID: 23236829
[TBL] [Abstract][Full Text] [Related]
28. The ameliorative effect of cerium oxide nanoparticles on chlorpyrifos induced hepatotoxicity in a rat model: Biochemical, molecular and immunohistochemical study.
Abdel-Karim RI; Hashish RK; Badran DI; Mohammed SS; Salem NA
J Trace Elem Med Biol; 2024 Jan; 81():127346. PubMed ID: 38000167
[TBL] [Abstract][Full Text] [Related]
29. A Brief Review on Cerium Oxide (CeO
Allu I; Kumar Sahi A; Kumari P; Sakhile K; Sionkowska A; Gundu S
Micromachines (Basel); 2023 Apr; 14(4):. PubMed ID: 37421098
[TBL] [Abstract][Full Text] [Related]
30. Hepatoprotective Effects of Grape Seed Procyanidin B2 in Rats With Carbon Tetrachloride-induced Hepatic Fibrosis.
Wang Z; Zhang Z; Du N; Wang K; Li L
Altern Ther Health Med; 2015; 21 Suppl 2():12-21. PubMed ID: 26308756
[TBL] [Abstract][Full Text] [Related]
31. Pan-caspase inhibitor VX-166 reduces fibrosis in an animal model of nonalcoholic steatohepatitis.
Witek RP; Stone WC; Karaca FG; Syn WK; Pereira TA; Agboola KM; Omenetti A; Jung Y; Teaberry V; Choi SS; Guy CD; Pollard J; Charlton P; Diehl AM
Hepatology; 2009 Nov; 50(5):1421-30. PubMed ID: 19676126
[TBL] [Abstract][Full Text] [Related]
32. Coating with polysaccharides influences the surface charge of cerium oxide nanoparticles and their effects to Mytilus galloprovincialis.
Nigro L; Freitas R; Maggioni D; Hamza H; Coppola F; Protano G; Della Torre C
NanoImpact; 2021 Oct; 24():100362. PubMed ID: 35559821
[TBL] [Abstract][Full Text] [Related]
33. Protective effects of cerium oxide and yttrium oxide nanoparticles on reduction of oxidative stress induced by sub-acute exposure to diazinon in the rat pancreas.
Khaksar MR; Rahimifard M; Baeeri M; Maqbool F; Navaei-Nigjeh M; Hassani S; Moeini-Nodeh S; Kebriaeezadeh A; Abdollahi M
J Trace Elem Med Biol; 2017 May; 41():79-90. PubMed ID: 28347467
[TBL] [Abstract][Full Text] [Related]
34. Cerium oxide nanoparticles improve liver regeneration after acetaminophen-induced liver injury and partial hepatectomy in rats.
Córdoba-Jover B; Arce-Cerezo A; Ribera J; Pauta M; Oró D; Casals G; Fernández-Varo G; Casals E; Puntes V; Jiménez W; Morales-Ruiz M
J Nanobiotechnology; 2019 Oct; 17(1):112. PubMed ID: 31672158
[TBL] [Abstract][Full Text] [Related]
35. Combined cerium and zinc oxide nanoparticles induced hepato-renal damage in rats through oxidative stress mediated inflammation.
Adeniyi OE; Adebayo OA; Akinloye O; Adaramoye OA
Sci Rep; 2023 May; 13(1):8513. PubMed ID: 37231036
[TBL] [Abstract][Full Text] [Related]
36. A Nutraceutical Rich in Docosahexaenoic Acid Improves Portal Hypertension in a Preclinical Model of Advanced Chronic Liver Disease.
Boyer-Diaz Z; Domingo JC; De Gregorio E; Manicardi N; Aristu-Zabalza P; Cordobilla B; Abad-Jordà L; Ortega-Ribera M; Fernández-Iglesias A; Marí M; Bosch J; Gracia-Sancho J
Nutrients; 2019 Oct; 11(10):. PubMed ID: 31623374
[TBL] [Abstract][Full Text] [Related]
37. Decoding cell death signals in liver inflammation.
Brenner C; Galluzzi L; Kepp O; Kroemer G
J Hepatol; 2013 Sep; 59(3):583-94. PubMed ID: 23567086
[TBL] [Abstract][Full Text] [Related]
38. [The effect of Ginkgo biloba extract on portal hypertension and hepatic microcirculation in rats].
Zhang CQ; Zhu YH; Wang J; Liang B; Xu HW; Qin CY
Zhonghua Gan Zang Bing Za Zhi; 2007 Apr; 15(4):245-8. PubMed ID: 17456308
[TBL] [Abstract][Full Text] [Related]
39. Alginate coating modifies the biological effects of cerium oxide nanoparticles to the freshwater bivalve Dreissena polymorpha.
Della Torre C; Maggioni D; Nigro L; Farè F; Hamza H; Protano G; Magni S; Fontana M; Riccardi N; Chiara M; Caruso D; Binelli A
Sci Total Environ; 2021 Jun; 773():145612. PubMed ID: 33582348
[TBL] [Abstract][Full Text] [Related]
40. Effect of udenafil on portal venous pressure and hepatic fibrosis in rats. A novel therapeutic option for portal hypertension.
Choi SM; Shin JH; Kim JM; Lee CH; Kang KK; Ahn BO; Yoo M
Arzneimittelforschung; 2009; 59(12):641-6. PubMed ID: 20108650
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]